abstract |
The present invention relates to the field of chemistry, more particularly therapeutic chemistry. In particular, the present invention is a novel contraceptive composition comprising progesterone and estrogen, wherein nomegestrol is used as an active agent, used or mixed with inert, non-toxic, pharmaceutically compatible excipients suitable for oral administration and A novel pharmaceutical composition for contraception characterized by containing an ester of estradiol. |